Skip to content

MSBase- An international Registry dedicated to evaluating outcomes data in Multiple Sclerosis

MSBase- An international Registry dedicated to evaluating outcomes data in Multiple Sclerosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12605000455662
Acronym
MSBase
Enrollment
10000
Registered
2005-09-21
Start date
2003-06-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The MSBase Registry is a longitudinal, strictly observational Multiple Sclerosis database open to all practicing Neurologists worldwide. In collaboration with participating Neurologists, the MSBase Registry has established a unique, web-based platform dedicated to sharing, tracking and evaluating outcomes data in Multiple Sclerosis (MS). In particular, MSBase aims to advance multi-centre, multi-national epidemiological and outcomes research by providing a freely accessible resource to compile, combine, compare and analyse large datasets. Participating Neurologists submit anonymized core clinical information using the freely available iMed software as a standardized data collection instrument. The core data to be collected is termed the minimum dataset, comprising key parameters relating to diagnosis, serial neurological examinations (Kurtzke Functional Score and Expanded Disability Status Score, EDSS), relapse information and treatment exposures. All aspects of patient management are entirely at the discretion of the managing neurologist and his or her patient. Anonymized aggregate data generated from the MSBase Registry will be reported to participating Neurologists on a regular basis. Important findings will be shared with the general neurology community at scientific meetings and through journal publications. The MSBase Scientific Advisory Board (SAB) acts as the custodian of the composite data, while individual datasets at all times remain the property of the participating physician. The MSBase SAB will ensure data integrity and monitor all MSBase activities including core study designs, promotion and implementation, and perform composite data analyses.

Interventions

The MSBase study is an ongoing, observational registry tracking the natural history of Multiple Sclerosis in the long term. In collaboration with participating neurologists the MSBase Registry will establish a unique international database for tracking and evaluating outcomes data in MS.

Sponsors

MSBase Foundation Ltd
Lead SponsorCharities/Societies/Foundations

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No

Inclusion criteria

All patients with Clinically Isolated Syndromes/ First Demyelinating Events suggestive of MS and all patients with Multiple Sclerosis are eligible provided the neurologist maintains the standardised minimum dataset including annual assessment of the patients Expanded Disability Status Score.

Exclusion criteria

No exclusion criteria

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 15, 2026